Report Detail

Service & Software Global Biopharma Contract Manufacturing Market Size, Status and Forecast 2021-2027

  • RnM4303184
  • |
  • 10 April, 2021
  • |
  • Global
  • |
  • 122 Pages
  • |
  • QYResearch
  • |
  • Service & Software

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Biopharma Contract Manufacturing Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
    • 1.2.2 Manufacturing
    • 1.2.3 Research
  • 1.3 Market by Application
    • 1.3.1 Global Biopharma Contract Manufacturing Market Share by Application: 2016 VS 2021 VS 2027
    • 1.3.2 Small Medium Enterprise
    • 1.3.3 Large Enterprise
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Biopharma Contract Manufacturing Market Perspective (2016-2027)
  • 2.2 Biopharma Contract Manufacturing Growth Trends by Regions
    • 2.2.1 Biopharma Contract Manufacturing Market Size by Regions: 2016 VS 2021 VS 2027
    • 2.2.2 Biopharma Contract Manufacturing Historic Market Share by Regions (2016-2021)
    • 2.2.3 Biopharma Contract Manufacturing Forecasted Market Size by Regions (2022-2027)
  • 2.3 Biopharma Contract Manufacturing Industry Dynamic
    • 2.3.1 Biopharma Contract Manufacturing Market Trends
    • 2.3.2 Biopharma Contract Manufacturing Market Drivers
    • 2.3.3 Biopharma Contract Manufacturing Market Challenges
    • 2.3.4 Biopharma Contract Manufacturing Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Biopharma Contract Manufacturing Players by Revenue
    • 3.1.1 Global Top Biopharma Contract Manufacturing Players by Revenue (2016-2021)
    • 3.1.2 Global Biopharma Contract Manufacturing Revenue Market Share by Players (2016-2021)
  • 3.2 Global Biopharma Contract Manufacturing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Biopharma Contract Manufacturing Revenue
  • 3.4 Global Biopharma Contract Manufacturing Market Concentration Ratio
    • 3.4.1 Global Biopharma Contract Manufacturing Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Biopharma Contract Manufacturing Revenue in 2020
  • 3.5 Biopharma Contract Manufacturing Key Players Head office and Area Served
  • 3.6 Key Players Biopharma Contract Manufacturing Product Solution and Service
  • 3.7 Date of Enter into Biopharma Contract Manufacturing Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Biopharma Contract Manufacturing Breakdown Data by Type

  • 4.1 Global Biopharma Contract Manufacturing Historic Market Size by Type (2016-2021)
  • 4.2 Global Biopharma Contract Manufacturing Forecasted Market Size by Type (2022-2027)

5 Biopharma Contract Manufacturing Breakdown Data by Application

  • 5.1 Global Biopharma Contract Manufacturing Historic Market Size by Application (2016-2021)
  • 5.2 Global Biopharma Contract Manufacturing Forecasted Market Size by Application (2022-2027)

6 North America

  • 6.1 North America Biopharma Contract Manufacturing Market Size (2016-2027)
  • 6.2 North America Biopharma Contract Manufacturing Market Size by Type
    • 6.2.1 North America Biopharma Contract Manufacturing Market Size by Type (2016-2021)
    • 6.2.2 North America Biopharma Contract Manufacturing Market Size by Type (2022-2027)
    • 6.2.3 North America Biopharma Contract Manufacturing Market Size by Type (2016-2027)
  • 6.3 North America Biopharma Contract Manufacturing Market Size by Application
    • 6.3.1 North America Biopharma Contract Manufacturing Market Size by Application (2016-2021)
    • 6.3.2 North America Biopharma Contract Manufacturing Market Size by Application (2022-2027)
    • 6.3.3 North America Biopharma Contract Manufacturing Market Size by Application (2016-2027)
  • 6.4 North America Biopharma Contract Manufacturing Market Size by Country
    • 6.4.1 North America Biopharma Contract Manufacturing Market Size by Country (2016-2021)
    • 6.4.2 North America Biopharma Contract Manufacturing Market Size by Country (2022-2027)
    • 6.4.3 United States
    • 6.4.4 Canada

7 Europe

  • 7.1 Europe Biopharma Contract Manufacturing Market Size (2016-2027)
  • 7.2 Europe Biopharma Contract Manufacturing Market Size by Type
    • 7.2.1 Europe Biopharma Contract Manufacturing Market Size by Type (2016-2021)
    • 7.2.2 Europe Biopharma Contract Manufacturing Market Size by Type (2022-2027)
    • 7.2.3 Europe Biopharma Contract Manufacturing Market Size by Type (2016-2027)
  • 7.3 Europe Biopharma Contract Manufacturing Market Size by Application
    • 7.3.1 Europe Biopharma Contract Manufacturing Market Size by Application (2016-2021)
    • 7.3.2 Europe Biopharma Contract Manufacturing Market Size by Application (2022-2027)
    • 7.3.3 Europe Biopharma Contract Manufacturing Market Size by Application (2016-2027)
  • 7.4 Europe Biopharma Contract Manufacturing Market Size by Country
    • 7.4.1 Europe Biopharma Contract Manufacturing Market Size by Country (2016-2021)
    • 7.4.2 Europe Biopharma Contract Manufacturing Market Size by Country (2022-2027)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic

8 Asia-Pacific

  • 8.1 Asia-Pacific Biopharma Contract Manufacturing Market Size (2016-2027)
  • 8.2 Asia-Pacific Biopharma Contract Manufacturing Market Size by Type
    • 8.2.1 Asia-Pacific Biopharma Contract Manufacturing Market Size by Type (2016-2021)
    • 8.2.2 Asia-Pacific Biopharma Contract Manufacturing Market Size by Type (2022-2027)
    • 8.2.3 Asia-Pacific Biopharma Contract Manufacturing Market Size by Type (2016-2027)
  • 8.3 Asia-Pacific Biopharma Contract Manufacturing Market Size by Application
    • 8.3.1 Asia-Pacific Biopharma Contract Manufacturing Market Size by Application (2016-2021)
    • 8.3.2 Asia-Pacific Biopharma Contract Manufacturing Market Size by Application (2022-2027)
    • 8.3.3 Asia-Pacific Biopharma Contract Manufacturing Market Size by Application (2016-2027)
  • 8.4 Asia-Pacific Biopharma Contract Manufacturing Market Size by Region
    • 8.4.1 Asia-Pacific Biopharma Contract Manufacturing Market Size by Region (2016-2021)
    • 8.4.2 Asia-Pacific Biopharma Contract Manufacturing Market Size by Region (2022-2027)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Biopharma Contract Manufacturing Market Size (2016-2027)
  • 9.2 Latin America Biopharma Contract Manufacturing Market Size by Type
    • 9.2.1 Latin America Biopharma Contract Manufacturing Market Size by Type (2016-2021)
    • 9.2.2 Latin America Biopharma Contract Manufacturing Market Size by Type (2022-2027)
    • 9.2.3 Latin America Biopharma Contract Manufacturing Market Size by Type (2016-2027)
  • 9.3 Latin America Biopharma Contract Manufacturing Market Size by Application
    • 9.3.1 Latin America Biopharma Contract Manufacturing Market Size by Application (2016-2021)
    • 9.3.2 Latin America Biopharma Contract Manufacturing Market Size by Application (2022-2027)
    • 9.3.3 Latin America Biopharma Contract Manufacturing Market Size by Application (2016-2027)
  • 9.4 Latin America Biopharma Contract Manufacturing Market Size by Country
    • 9.4.1 Latin America Biopharma Contract Manufacturing Market Size by Country (2016-2021)
    • 9.4.2 Latin America Biopharma Contract Manufacturing Market Size by Country (2022-2027)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Biopharma Contract Manufacturing Market Size (2016-2027)
  • 10.2 Middle East & Africa Biopharma Contract Manufacturing Market Size by Type
    • 10.2.1 Middle East & Africa Biopharma Contract Manufacturing Market Size by Type (2016-2021)
    • 10.2.2 Middle East & Africa Biopharma Contract Manufacturing Market Size by Type (2022-2027)
    • 10.2.3 Middle East & Africa Biopharma Contract Manufacturing Market Size by Type (2016-2027)
  • 10.3 Middle East & Africa Biopharma Contract Manufacturing Market Size by Application
    • 10.3.1 Middle East & Africa Biopharma Contract Manufacturing Market Size by Application (2016-2021)
    • 10.3.2 Middle East & Africa Biopharma Contract Manufacturing Market Size by Application (2022-2027)
    • 10.3.3 Middle East & Africa Biopharma Contract Manufacturing Market Size by Application (2016-2027)
  • 10.4 Middle East & Africa Biopharma Contract Manufacturing Market Size by Country
    • 10.4.1 Middle East & Africa Biopharma Contract Manufacturing Market Size by Country (2016-2021)
    • 10.4.2 Middle East & Africa Biopharma Contract Manufacturing Market Size by Country (2022-2027)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 Catalent
    • 11.1.1 Catalent Company Details
    • 11.1.2 Catalent Business Overview
    • 11.1.3 Catalent Biopharma Contract Manufacturing Introduction
    • 11.1.4 Catalent Revenue in Biopharma Contract Manufacturing Business (2016-2021)
    • 11.1.5 Catalent Recent Development
  • 11.2 Pharmaceutical Product Development LLC
    • 11.2.1 Pharmaceutical Product Development LLC Company Details
    • 11.2.2 Pharmaceutical Product Development LLC Business Overview
    • 11.2.3 Pharmaceutical Product Development LLC Biopharma Contract Manufacturing Introduction
    • 11.2.4 Pharmaceutical Product Development LLC Revenue in Biopharma Contract Manufacturing Business (2016-2021)
    • 11.2.5 Pharmaceutical Product Development LLC Recent Development
  • 11.3 AbbVie
    • 11.3.1 AbbVie Company Details
    • 11.3.2 AbbVie Business Overview
    • 11.3.3 AbbVie Biopharma Contract Manufacturing Introduction
    • 11.3.4 AbbVie Revenue in Biopharma Contract Manufacturing Business (2016-2021)
    • 11.3.5 AbbVie Recent Development
  • 11.4 Baxter BioPharma Solutions
    • 11.4.1 Baxter BioPharma Solutions Company Details
    • 11.4.2 Baxter BioPharma Solutions Business Overview
    • 11.4.3 Baxter BioPharma Solutions Biopharma Contract Manufacturing Introduction
    • 11.4.4 Baxter BioPharma Solutions Revenue in Biopharma Contract Manufacturing Business (2016-2021)
    • 11.4.5 Baxter BioPharma Solutions Recent Development
  • 11.5 Patheon
    • 11.5.1 Patheon Company Details
    • 11.5.2 Patheon Business Overview
    • 11.5.3 Patheon Biopharma Contract Manufacturing Introduction
    • 11.5.4 Patheon Revenue in Biopharma Contract Manufacturing Business (2016-2021)
    • 11.5.5 Patheon Recent Development
  • 11.6 Grifols International
    • 11.6.1 Grifols International Company Details
    • 11.6.2 Grifols International Business Overview
    • 11.6.3 Grifols International Biopharma Contract Manufacturing Introduction
    • 11.6.4 Grifols International Revenue in Biopharma Contract Manufacturing Business (2016-2021)
    • 11.6.5 Grifols International Recent Development
  • 11.7 Dalton Pharma Services
    • 11.7.1 Dalton Pharma Services Company Details
    • 11.7.2 Dalton Pharma Services Business Overview
    • 11.7.3 Dalton Pharma Services Biopharma Contract Manufacturing Introduction
    • 11.7.4 Dalton Pharma Services Revenue in Biopharma Contract Manufacturing Business (2016-2021)
    • 11.7.5 Dalton Pharma Services Recent Development
  • 11.8 Boehringer Ingelheim Biopharmaceuticals GmBh
    • 11.8.1 Boehringer Ingelheim Biopharmaceuticals GmBh Company Details
    • 11.8.2 Boehringer Ingelheim Biopharmaceuticals GmBh Business Overview
    • 11.8.3 Boehringer Ingelheim Biopharmaceuticals GmBh Biopharma Contract Manufacturing Introduction
    • 11.8.4 Boehringer Ingelheim Biopharmaceuticals GmBh Revenue in Biopharma Contract Manufacturing Business (2016-2021)
    • 11.8.5 Boehringer Ingelheim Biopharmaceuticals GmBh Recent Development
  • 11.9 Lonza AG.
    • 11.9.1 Lonza AG. Company Details
    • 11.9.2 Lonza AG. Business Overview
    • 11.9.3 Lonza AG. Biopharma Contract Manufacturing Introduction
    • 11.9.4 Lonza AG. Revenue in Biopharma Contract Manufacturing Business (2016-2021)
    • 11.9.5 Lonza AG. Recent Development
  • 11.10 QuintilesIMS
    • 11.10.1 QuintilesIMS Company Details
    • 11.10.2 QuintilesIMS Business Overview
    • 11.10.3 QuintilesIMS Biopharma Contract Manufacturing Introduction
    • 11.10.4 QuintilesIMS Revenue in Biopharma Contract Manufacturing Business (2016-2021)
    • 11.10.5 QuintilesIMS Recent Development
  • 11.11 Vetter Pharma
    • 11.11.1 Vetter Pharma Company Details
    • 11.11.2 Vetter Pharma Business Overview
    • 11.11.3 Vetter Pharma Biopharma Contract Manufacturing Introduction
    • 11.11.4 Vetter Pharma Revenue in Biopharma Contract Manufacturing Business (2016-2021)
    • 11.11.5 Vetter Pharma Recent Development
  • 11.12 Ligand Pharmaceuticals, Inc.
    • 11.12.1 Ligand Pharmaceuticals, Inc. Company Details
    • 11.12.2 Ligand Pharmaceuticals, Inc. Business Overview
    • 11.12.3 Ligand Pharmaceuticals, Inc. Biopharma Contract Manufacturing Introduction
    • 11.12.4 Ligand Pharmaceuticals, Inc. Revenue in Biopharma Contract Manufacturing Business (2016-2021)
    • 11.12.5 Ligand Pharmaceuticals, Inc. Recent Development
  • 11.13 Bausch Health
    • 11.13.1 Bausch Health Company Details
    • 11.13.2 Bausch Health Business Overview
    • 11.13.3 Bausch Health Biopharma Contract Manufacturing Introduction
    • 11.13.4 Bausch Health Revenue in Biopharma Contract Manufacturing Business (2016-2021)
    • 11.13.5 Bausch Health Recent Development
  • 11.14 Recipharm AB
    • 11.14.1 Recipharm AB Company Details
    • 11.14.2 Recipharm AB Business Overview
    • 11.14.3 Recipharm AB Biopharma Contract Manufacturing Introduction
    • 11.14.4 Recipharm AB Revenue in Biopharma Contract Manufacturing Business (2016-2021)
    • 11.14.5 Recipharm AB Recent Development
  • 11.15 Famar Health Care Services
    • 11.15.1 Famar Health Care Services Company Details
    • 11.15.2 Famar Health Care Services Business Overview
    • 11.15.3 Famar Health Care Services Biopharma Contract Manufacturing Introduction
    • 11.15.4 Famar Health Care Services Revenue in Biopharma Contract Manufacturing Business (2016-2021)
    • 11.15.5 Famar Health Care Services Recent Development
  • 11.16 West Pharmaceutical Services, Inc.
    • 11.16.1 West Pharmaceutical Services, Inc. Company Details
    • 11.16.2 West Pharmaceutical Services, Inc. Business Overview
    • 11.16.3 West Pharmaceutical Services, Inc. Biopharma Contract Manufacturing Introduction
    • 11.16.4 West Pharmaceutical Services, Inc. Revenue in Biopharma Contract Manufacturing Business (2016-2021)
    • 11.16.5 West Pharmaceutical Services, Inc. Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Global Biopharma Contract Manufacturing Scope and Market Size
    Biopharma Contract Manufacturing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Biopharma Contract Manufacturing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

    Segment by Type
    Manufacturing
    Research

    Segment by Application
    Small Medium Enterprise
    Large Enterprise

    By Region
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia
    Latin America
    Mexico
    Brazil
    Rest of Latin America
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of MEA

    By Company
    Catalent
    Pharmaceutical Product Development LLC
    AbbVie
    Baxter BioPharma Solutions
    Patheon
    Grifols International
    Dalton Pharma Services
    Boehringer Ingelheim Biopharmaceuticals GmBh
    Lonza AG.
    QuintilesIMS
    Vetter Pharma
    Ligand Pharmaceuticals, Inc.
    Bausch Health
    Recipharm AB
    Famar Health Care Services
    West Pharmaceutical Services, Inc.


    Summary:
    Get latest Market Research Reports on Biopharma Contract Manufacturing. Industry analysis & Market Report on Biopharma Contract Manufacturing is a syndicated market report, published as Global Biopharma Contract Manufacturing Market Size, Status and Forecast 2021-2027. It is complete Research Study and Industry Analysis of Biopharma Contract Manufacturing market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,900.00
    $5,850.00
    $7,800.00
    2,808.00
    4,212.00
    5,616.00
    3,233.10
    4,849.65
    6,466.20
    426,387.00
    639,580.50
    852,774.00
    288,249.00
    432,373.50
    576,498.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report